Pamela Scherer Mcleod from darkdaily.com wrote a very interesting article on how next-gen gene sequencing is affecting clinical research. Gene testing of patients enrolled in advanced cancer clinical trials may be able to supplement or even replace traditional enrolment. The reason for this is that next-generation gene sequencing is demonstrating that a “molecular triage” model for a clinical trial may increase effectiveness, reduce costs, and shorten development time. To read the full article click here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Imposter Participants: Fake Participants Causing Real Problems
2025 Holiday Schedule
OHRP’s Proposed Changes to the Federalwide Assurance Form: An Update
The Latest Federal Funding Cuts and Their Impact on Ethical Clinical Research Oversight
Chevron, Natural Resources Defense Council, Loper Bright Enterprises, Raimondo, et al.